1 Dec 2014

Top 10 blockbuster pharmaceuticals by sales worldwide in 2013

Posted Byadmin

Comments0

Tagsglobal 10 top pharmaceuticals, humira, top 10 blockbuster drug, top 10 drugs, top 10 drugs globally, top 10 drugs in 2014, top 10 pharmaceuticals globally, top biologic

Drugs which generates annual sales of at least $1 billion for the company is called blockbuster drugs. Followings are the top 10 blockbuster drugs in terms of sales in 2013.

Humira 10.7 BillionAbbVie

Enbrel 8.776 Billion-Amgen, Pfizer, Takeda

Remicade 8.38 Billion – Janssen, Merck, Mitsubishi Tanabe Pharma

Advair/Seretide – GlaxoSmithKline / 7.86 Billion

Lantus 7.59 Billion Sanofi

Rituxan/MabThera $7.50 billion – Roche, Biogen Idec

Avastin $6.751 billion Roche

Herceptin $6.56 billion Roche

Crestor – AstraZeneca $6.044 billion

Abilify $5.501 billion Bristol-Myers Squibb, Otsuka

Important fact:

1. Humira – The anti-inflammatory drug Humira was not only the best-selling biologic; it was the the best-selling drug worldwide, period.

2. In the top 10 list, there are 7 biologics – Humira – Adalimumab, Remicade – Infliximab, Rituxan – Rituximab, Enbrel-Etanercept, Lantus – Insulin glargine [rDNA origin] injection, Avastin – Bevacizumab, Herceptin – Trastuzumab.

Source: Company annual report.